Autopsy report · NCT02199223

Regorafenib + Panitumumab for Colorectal Cancers

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“Slow accrual”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 1 year 11 months before it stopped.
2 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: University of Utah
Sponsor type: University, hospital or other
Conditions: KRAS and NRAS Wild-type Colorectal Cancer
Interventions: regorafenib + panitumumab
Participants: 2
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.